Using RT-PCR and FISH methods, ALK gene rearrangement was confirmed in three adenocarcinoma patients (6.25% of all patients, 2 female and one male, non-smoking patients) who expressed abnormal ALK protein on 60%-80% of tumor cells. Here, ALK is linked to adenocarcinoma.